Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22163860 | 0.83 | — | — | |
| SCHEMBL15969015 | 0.80 | PSEN1 (0.31) | — | |
| SCHEMBL342325 | 0.80 | PSEN1 (0.31) | — | |
| SCHEMBL2431617 | 0.76 | MGLL (0.30) | — | |
| SCHEMBL29111500 | 0.75 | PSEN1 (0.32) | — | |
| SCHEMBL2511023 | 0.75 | — | — | |
| SCHEMBL28366699 | 0.74 | — | — | |
| SCHEMBL10446959 | 0.73 | PSEN1 (0.31) | — | |
| SCHEMBL28921010 | 0.73 | PSEN1 (0.31) | — | |
| SCHEMBL28646512 | 0.72 | MGLL (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10689428-B2 | Polypeptides, nucleic acids and uses thereof | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2020-06-23 | — | — | US | disclosed |
| US-20180265559-A1 | POLYPEPTIDES, NUCLEIC ACIDS AND USES THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2018-09-20 | — | — | US | disclosed |
| US-9309314-B2 | Polypeptides, nucleic acids and uses thereof | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (A*STAR) (SG) | 2016-04-12 | — | — | US | disclosed |
| US-20160054300-A1 | REFERENCE STANDARD FOR DIAGNOSTIC APPLICATIONS | WINTHER LARS (DK) | 2016-02-25 | — | — | US | disclosed |
| US-20150299311-A1 | POLYPEPTIDES, NUCLEIC ACIDS AND USES THEREOF | AGENCY SCIENCE TECH & RES (SG) | 2015-10-22 | — | — | US | disclosed |
| US-20150153365-A1 | POLYPEPTIDES, NUCLEIC ACIDS AND USES THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (A*STAR) (SG) | 2015-06-04 | — | — | US | disclosed |
| EP-1642131-B1 | STANDARD | DAKO DENMARK AS (DK) | 2008-10-29 | — | — | EP | disclosed |
| US-20070037138-A1 | Standard for immunohistochemistry, immunocytochemistry and molecular cytogenetics | DAKOCYTOMATION DENMARK A/S (DK) | 2007-02-15 | — | — | US | disclosed |
| EP-1597578-B1 | STANDARD FOR IMMUNOHISTOCHEMISTRY, IMMUNOCYTOCHEMISTRY AND MOLECULAR CYTOGENETICS. | DAKO DENMARK AS (DK) | 2006-12-20 | — | — | EP | disclosed |
| US-20060154234-A1 | Standard | WINTHER LARS | 2006-07-13 | — | — | US | disclosed |
| EP-0438206-B1 | 6-Ring-containing macrocyclic tetraaza compounds, processes for their preparation, and pharmaceutical agents containing them | SCHERING AG (DE) | 1996-08-21 | — | — | EP | disclosed |
| EP-0516063-A1 | Antibody-enzyme complex and enzyme immunoassay using it | SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. (JP) | 1992-12-02 | — | — | EP | disclosed |
| EP-0441468-A2 | Gas-containing microparticles composed of polyaldehydes as contrast agents | SCHERING AKTIENGESELLSCHAFT (DE) | 1991-08-14 | — | — | EP | disclosed |
| EP-0438206-A1 | 6-Ring-containing macrocyclic tetraaza compounds, processes for their preparation, and pharmaceutical agents containing them | SCHERING AKTIENGESELLSCHAFT (DE) | 1991-07-24 | — | — | EP | disclosed |
| EP-0430863-A2 | Complexe builders bonded to sterwise prepared polymers, their complexes and conjugates, process for their preparation and pharmaceutical agents containing the same | SCHERING AKTIENGESELLSCHAFT (DE) | 1991-06-05 | — | — | EP | disclosed |
| EP-0149168-B1 | IMMUNOASSAY | DAIICHI PURE CHEMICALS CO. LTD. (JP) | 1991-04-24 | — | — | EP | disclosed |
| EP-0331616-A2 | Polymer-bonded complexe builders, their complexes, process for their preparation and pharmaceutical agents containing the same | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-09-06 | — | — | EP | disclosed |
| EP-0277088-A2 | Polymer complexes, process for their preparation and pharmaceutical compounds containing them | SCHERING AKTIENGESELLSCHAFT (DE) | 1988-08-03 | — | — | EP | disclosed |
| US-4690907-A | Capillary tube immunoassay | DAIICHI PURE CHEMICALS CO., LTD. (JP) | 1987-09-01 | — | — | US | disclosed |
| EP-0149168-A1 | Immunoassay | DAIICHI PURE CHEMICALS CO. LTD. (JP) | 1985-07-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180265559-A1 | POLYPEPTIDES, NUCLEIC ACIDS AND USES THEREOF | CXXC4, CXXC5, ZFX | PTGS1 4744/4885PTGS2 4825/4885 |
| US-20150153365-A1 | POLYPEPTIDES, NUCLEIC ACIDS AND USES THEREOF | CXXC4, CXXC5, ZFX | PTGS1 4744/4885PTGS2 4825/4885 |
| US-20150299311-A1 | POLYPEPTIDES, NUCLEIC ACIDS AND USES THEREOF | CXXC4, CXXC5, ZFX | PTGS1 4744/4885PTGS2 4825/4885 |
| US-10689428-B2 | Polypeptides, nucleic acids and uses thereof | CXXC4, CXXC5, ZFX | PTGS1 4744/4885PTGS2 4825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.